Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
4
Mins
1 Jun 2026
Microbiome Modulation as a Determinant of Cancer Therapy Response
THE ROLE of the microbiome as a modulator of cancer therapy response has become a key topic in recent oncology research. At the European…
1 Jun 2026
Sex Differences in Alzheimer’s Disease
In this series, host Catherine Glass speaks with Rachel Buckley about how Alzheimer’s disease risk and progression…
1 Jun 2026
Cancer Risk Prediction Highlights Screening Inequalities
Individualised cancer risk models revealed marked variation in lifetime and 10-year cancer risk, with healthy behaviours associated with substantial risk reduction.
1 Jun 2026
ASCO 2026: Darolutamide Shows Cognitive Edge in Prostate Cancer
Darolutamide showed less cognitive decline than enzalutamide in ARACOG results presented at ASCO 2026 for prostate cancer.
1 Jun 2026
Phase 3 Trial Supports Ecopipam for Tourette Syndrome
A phase 3 trial has found ecopipam reduces relapse risk and maintains tic improvement in children and adolescents with Tourette syndrome.
1 Jun 2026
Global Study Examines Educational Impact of Atopic Dermatitis
International study finds childhood-onset atopic dermatitis may limit education, career choices, and psychosocial wellbeing into adulthood.
1 Jun 2026
Patient-Centered Lupus Apps Show Clinical Potential
Lupus erythematosus mobile apps may support disease management, but a systematic review found few meet patient-centered standards.
1 Jun 2026
Stress Linked to Faster Liver Cancer Progression Through Microbiome
Stress may accelerate hepatocellular carcinoma progression by altering gut microbiota and tumour immune signalling, according to new preclinical and clinical research identifying a stress–gut–tumour axis.
1 Jun 2026
Joint Swelling in Children May Signal Arthritis
Rice body synovitis in children is most often linked to juvenile idiopathic arthritis, pooled evidence suggests.
31 May 2026
ASCO 2026: New First-Line Option Emerges in Head and Neck Cancer
Head and neck cancer survival improved with TMC-I versus platinum chemotherapy in recurrent or metastatic disease.
←
1
2
3
…
7
8
9
10
11
12
13
…
1,624
1,625
1,626
→
We’ve noticed you’re accessing
from
North/South America.
View
View